← Companies|Phathom Pharma
PH

Phathom Pharma

PHAT·NASDAQFlorham Park NJFounded 2018100 employees
Small CapbiotechPublicGI
Platform: Vonoprazan GERD
Market Cap
$0.8B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PHAT)
Loading PHAT stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
PHA-9567PHA-9567Phase 2/32Small MoleculeHPK1iIPF
TirazanubrutinibPHA-1734Preclinical2mRNACDK2PD-L1iSCLC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)
2025-02-20
PHA-9567 Ph3 Readout
IPF
Past
2028-01-27
Tirazanubrutinib Interim
SCLC
Interim
2029-01-06
PHA-9567 Ph3 Readout
IPF
Ph3 Readout
2029-07-15
Tirazanubrutinib Interim
SCLC
Interim